Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Cristina Soria, Lola Prieto, Esther Lázaro & Amalia Ubeda. (2023) Factors Associated with Therapeutic Adherence in Multiple Sclerosis in Spain. Patient Preference and Adherence 17, pages 679-688.
Read now
Read now
Francesco Patti, María Luisa Martínez Ginés, Christiane Norenberg & Fernando Duarte Caron. (2020) BetaEval Global: Prospective, Multinational, Observational Cohort Study of Patients Using BETACONNECT®. Patient Preference and Adherence 14, pages 771-779.
Read now
Read now
Articles from other publishers (19)
Marianna G. Rispoli, Maria D’Apolito, Valeria Pozzilli & Valentina Tomassini. 2023. Precision Medicine in Neurodegenerative Disorders, Part II. Precision Medicine in Neurodegenerative Disorders, Part II
293
311
.
Sebastian Finkener, Lutz Achtnichts, Michaela Cervenakova, Krassen Nedeltchev & Oliver Findling. (2022) Oral disease modifying therapies – A game changer for treatment decision in untreated patients with RRMS and CIS? – A swiss single center cross-sectional study. Multiple Sclerosis and Related Disorders 68, pages 104396.
Crossref
Crossref
Mohammad Ali Sahraian, Amir Mohammad Salehi, Ensiyeh Jenabi, Maryam Etminani Esfahani & Sara Ataei. (2022) Post marketing new adverse effects of oral therapies in multiple sclerosis: A systematic review. Multiple Sclerosis and Related Disorders 68, pages 104157.
Crossref
Crossref
Derya GIRGIN, Zeynep TOSUN, Nilda TURGUT & Sibel GULER. (2022) The effect of social support, depression, and illness perception on treatment adherence in patients with multiple sclerosis. Marmara Medical Journal 35:3, pages 323-329.
Crossref
Crossref
Irene Andrade Andrade, Eduardo Tejedor Tejada, Elena Macías Cortés, Carmen Muñoz Fernández & Magdalena Martínez Martínez. (2022) Adherence to treatment with injectable immunomodulators in patients with multiple sclerosis and cognitive disorder. Revista Científica de la Sociedad de Enfermería Neurológica (English ed.) 56, pages 11-17.
Crossref
Crossref
Irene Andrade Andrade, Eduardo Tejedor Tejada, Elena Macías Cortés, Carmen Muñoz Fernández & Magdalena Martínez Martínez. (2022) Adherencia al tratamiento con inmunomoduladores inyectables en pacientes con esclerosis múltiple y trastorno cognitivo. Revista Científica de la Sociedad Española de Enfermería Neurológica 56, pages 11-17.
Crossref
Crossref
Ricardo Alonso, Juan I. Rojas, Juan Ramos, Patricio Correa, Cecilia Pita, Leila Cohen, Sandra Vanotti, Orlando Garcea & Berenice A. Silva. (2022) Evaluation of adherence to treatment in patients with multiple sclerosis from Latin America. Multiple Sclerosis and Related Disorders 63, pages 103915.
Crossref
Crossref
Emanuela Calandri, Federica Graziano, Martina Borghi & Silvia Bonino. (2021) The future between difficulties and resources: Exploring parents' perspective on young adults with multiple sclerosis. Family Relations 71:2, pages 686-706.
Crossref
Crossref
Seyed Mojtaba Kazemi, Mahnaz Rakhshan, Mozhgan Rivaz & Sadegh Izadi. (2022) The effects of continuous care model using a smartphone application on adherence to treatment and self-efficacy among patients with multiple sclerosis. BMC Medical Informatics and Decision Making 22:1.
Crossref
Crossref
Aleksandra Kołtuniuk & Justyna Chojdak-Łukasiewicz. (2022) Adherence to Therapy in Patients with Multiple Sclerosis—Review. International Journal of Environmental Research and Public Health 19:4, pages 2203.
Crossref
Crossref
Jihad S. Inshasi, Sarmed Alfahad, Taoufik Alsaadi, Ali Hassan, Tayseer Zein, Victoria Ann Mifsud, Suzan Ibrahim Nouri, Mustafa Shakra, Ahmed Osman Shatila, Miklos Szolics, Mona Thakre, Ajit Kumar & Amir Boshra. (2021) Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates. Neurology and Therapy 10:2, pages 435-454.
Crossref
Crossref
Carlos A Pérez & John A Lincoln. (2021) Racial and ethnic disparities in treatment response and tolerability in multiple sclerosis: A comparative study. Multiple Sclerosis and Related Disorders 56, pages 103248.
Crossref
Crossref
Adam BurkhardJoshua ToliverKaren Rascati. (2021) Association between multiple sclerosis disease severity and adherence to disease-modifying therapies. Journal of Managed Care & Specialty Pharmacy 27:7, pages 915-923.
Crossref
Crossref
Natalie J EngmannDanny SheinsonKomal BawaCarmen D NgGabriel Pardo. (2021) Persistence and adherence to ocrelizumab compared with other disease-modifying therapies for multiple sclerosis in U.S. commercial claims data. Journal of Managed Care & Specialty Pharmacy 27:5, pages 639-649.
Crossref
Crossref
Gisela Zanga, Estefania Drzewiscki, Paula Tagliani, Maximiliano Smietniansky, Maria M. Esnaola y Rojas & Diego Caruso. (2021) Predictors of adherence and persistence to disease-modifying therapies in Multiple Sclerosis. Therapeutic Advances in Neurological Disorders 14, pages 175628642110310.
Crossref
Crossref
Sanni Lahdenperä, Merja Soilu‐Hänninen, Hanna‐Maija Kuusisto, Sari Atula, Jouni Junnila & Anders Berglund. (2020) Medication adherence/persistence among patients with active multiple sclerosis in Finland. Acta Neurologica Scandinavica 142:6, pages 605-612.
Crossref
Crossref
Iria Sánchez Martínez, María Cerdán Sánchez, Javier López Román, Francisca Iniesta Martínez, Ester Carreón-Guarnizo, Jose-Eustasio Meca Lallana & Pilar Zafrilla Rentero. (2020) Possible Influence of the Route of Treatment Administration on Treatment Adherence in Patients With Multiple Sclerosis. Clinical Therapeutics 42:5, pages e87-e99.
Crossref
Crossref
Luca Prosperini, Antonio Cortese, Matteo Lucchini, Laura Boffa, Giovanna Borriello, Maria Chiara Buscarinu, Fioravante Capone, Diego Centonze, Chiara De Fino, Daniela De Pascalis, Roberta Fantozzi, Elisabetta Ferraro, Maria Filippi, Simonetta Galgani, Claudio Gasperini, Shalom Haggiag, Doriana Landi, Girolama Marfia, Giorgia Mataluni, Enrico Millefiorini, Massimiliano Mirabella, Fabrizia Monteleone, Viviana Nociti, Simona Pontecorvo, Silvia Romano, Serena Ruggieri, Marco Salvetti, Carla Tortorella, Silvana Zannino & Giancarlo Di Battista. (2019) Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study. Journal of Neurology 267:3, pages 694-702.
Crossref
Crossref
Celia Oreja-Guevara, Stanca Potra, Birgit Bauer, Diego Centonze, Maria-Paz Giambastiani, Gavin Giovannoni, Jürg Kesselring, Dawn Langdon, Sarah A. Morrow, Jocelyne Nouvet-Gire, Maija Pontaga, Peter Rieckmann, Sven Schippling, Nektaria Alexandri, Jane Shanahan, Heidi Thompson, Pieter Van Galen, Patrick Vermersch & David Yeandle. (2019) Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care. Advances in Therapy 36:11, pages 3238-3252.
Crossref
Crossref